Octarine Bio
PrivateLast Round
Series A
Extension
Jan 22, 2026
Total Funding Raised
$13.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Octarine Bio operates in Energy & Sustainability and is based in Copenhagen. Its latest recorded funding round was a Series A Extension round in January 2026.
Octarine Bio is a biotechnology company that develops sustainable, bio-based pigments and dyes for the textile, food, and personal care industries using synthetic biology and precision fermentation.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Octarine Bio Comparables
Compare Octarine Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Michroma | 86% | |
| Huue | 83% | |
| Pili | 83% |
For institutional investors. Book with your work email.
Octarine Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 22, 2026 | ||||
| Series A | Nov 8, 2023 | ||||
| VC Round | Sep 21, 2022 | ||||
| Seed | Mar 13, 2021 | ||||
| Seed | Nov 12, 2020 | ||||
Pre Seed | Jan 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Octarine Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Edaphon | Series A Extension |
| Unconventional Ventures | Series A Extension, Series A |
| The Footprint Firm | Series A, Series A Extension |
| Óskare Capital | Series A, Series A Extension, Seed, VC Round |
| The Export and Investment Fund of Denmark | Seed |
| DSM Venturing | VC Round |
| ENEXIS | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 297% MoM, reaching 1.4K.
- Jun 24, 2026
Grew 20% QoQ, from 25 to 30 employees.
For institutional investors. Book with your work email.
Octarine Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Octarine Bio's valuation, stock price, and market status.
Is Octarine Bio a public or private company?
Octarine Bio is a private company.
What is the current stock price of Octarine Bio?
Octarine Bio is a private company, so its shares have no public market price. Caplight tracks Octarine Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Octarine Bio worth (valuation)?
Valuation information for Octarine Bio is not publicly available.
Can I buy Octarine Bio stock?
Octarine Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Octarine Bio's last funding round?
Octarine Bio's most recent funding round was Series A Extension on January 22, 2026.
Who are the main investors in Octarine Bio?
Key investors in Octarine Bio include Unconventional Ventures, Óskare Capital, The Export and Investment Fund of Denmark, DSM Venturing.
Will Octarine Bio IPO soon?
No public IPO plans have been announced for Octarine Bio.
How can I track Octarine Bio secondary market activity?
Caplight tracks bids, offers, and trades in Octarine Bio's shares on secondary markets.